1. Home
  2. ASPN vs MYGN Comparison

ASPN vs MYGN Comparison

Compare ASPN & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aspen Aerogels Inc.

ASPN

Aspen Aerogels Inc.

N/A

Current Price

$4.91

Market Cap

407.5M

ML Signal

N/A

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$3.42

Market Cap

327.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASPN
MYGN
Founded
2001
1991
Country
United States
United States
Employees
854
2700
Industry
RETAIL: Building Materials
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
407.5M
327.1M
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
ASPN
MYGN
Price
$4.91
$3.42
Analyst Decision
Strong Buy
Buy
Analyst Count
4
7
Target Price
$4.25
$7.64
AVG Volume (30 Days)
744.9K
1.4M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$271,103,000.00
$771,400,000.00
Revenue This Year
N/A
$6.86
Revenue Next Year
$50.03
$5.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.33
52 Week Low
$2.30
$2.74
52 Week High
$9.35
$8.59

Technical Indicators

Market Signals
Indicator
ASPN
MYGN
Relative Strength Index (RSI) 39.74 37.01
Support Level $2.99 $2.83
Resistance Level $5.48 $3.31
Average True Range (ATR) 0.20 0.17
MACD -0.04 0.08
Stochastic Oscillator 6.66 40.00

Price Performance

Historical Comparison
ASPN
MYGN

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: